Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China flag China · Delayed Price · Currency is CNY
4.250
-0.170 (-3.85%)
Sep 11, 2026, 3:00 PM CST

SHA:600866 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
15,26515,29316,71016,89117,0743,970
Other Revenue
664.71607.51624.13482.72412.8100.95
15,93015,90017,33417,37417,4864,071
Revenue Growth
-6.34%-8.27%-0.23%-0.64%329.51%264.72%
Cost of Revenue
14,21513,35014,39314,97614,4883,276
Gross Profit
1,7142,5502,9422,3972,998794.87
Selling, General & Admin
1,1181,0711,076947.17935.84365.04
Research & Development
182.6182.02169.78179.31177.9898.83
Other Operating Expenses
108.59107.18104.9780.35118.98.21
Operating Expenses
1,4211,3701,3461,2131,236469.21
Operating Income
293.551,1801,5961,1851,762325.66
Interest Expense
-70.59-80.71-109.68-173.46-243.29-83.35
Interest & Investment Income
53.8952.0114.8521.4315.57.26
Currency Exchange Gain (Loss)
-47.3921.4137.4-8.33-76.916.6
Other Non Operating Income (Expenses)
-9.39-5.64-19.65-14.12-40.354.97
EBT Excluding Unusual Items
220.071,1671,5191,0101,417261.14
Impairment of Goodwill
---91.91-93.7-12.34-
Gain (Loss) on Sale of Investments
-2.1120.78-237.67-66.943.68.79
Gain (Loss) on Sale of Assets
-0.52-5.2928.690.34.350.83
Asset Writedown
-8.76-13.36-6.9-14.15-17.14-4.31
Other Unusual Items
74.3349.4221.9227.8827.7211.81
Pretax Income
283.011,2181,233863.621,424278.26
Income Tax Expense
67.11248.21283.27177.92240.5629.18
Earnings From Continuing Operations
215.9970.04949.81685.71,183249.07
Minority Interest in Earnings
-2.578.85-6.66-7.74-574.66-96.94
Net Income
213.33978.89943.15677.95608.33152.14
Net Income to Common
213.33978.89943.15677.95608.33152.14
Net Income Growth
-83.25%3.79%39.12%11.45%299.85%2.31%
Shares Outstanding (Basic)
1,6611,6611,6611,6621,188807
Shares Outstanding (Diluted)
1,6611,6611,6611,6621,188807
Shares Change
-0.06%0.00%-0.02%39.91%47.23%9.14%
EPS (Basic)
0.130.590.570.410.510.19
EPS (Diluted)
0.130.590.570.410.510.19
EPS Growth
-83.24%3.79%39.14%-20.34%171.58%-6.26%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,155-746.521,7591,6501,210-181.59
Free Cash Flow Per Share
-1.30-0.451.060.991.02-0.23
Dividend Per Share
0.3800.3800.3800.380--
Dividend Growth
0%0%0%---
Gross Margin
10.76%16.04%16.97%13.80%17.15%19.52%
Operating Margin
1.84%7.42%9.21%6.82%10.08%8.00%
Profit Margin
1.34%6.16%5.44%3.90%3.48%3.74%
Free Cash Flow Margin
-13.53%-4.70%10.15%9.50%6.92%-4.46%
EBITDA
1,1552,0132,4342,0352,742429.11
EBITDA Margin
7.25%12.66%14.04%11.71%15.68%10.54%
D&A For EBITDA
861.12833.19838.18850.63979.49103.45
EBIT
293.551,1801,5961,1851,762325.66
EBIT Margin
1.84%7.42%9.21%6.82%10.08%8.00%
Effective Tax Rate
23.71%20.38%22.97%20.60%16.90%10.49%
Revenue as Reported
15,93015,90017,33417,37417,4864,071
Advertising Expenses
-2051.0562.4217.74.96